首页 > 最新文献

Postgraduate Medicine最新文献

英文 中文
Pediatric emergency revisits of children with COVID-19. COVID-19患儿的儿科急诊就诊情况。
IF 4.2 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-05-01 DOI: 10.1080/00325481.2022.2157634
Leman Akcan Yildiz, Oznur Karaca Vural, Ali Kansu Tehci, Halise Akca, Funda Kurt, Ayla Akca Caglar, Emine Dibek Misirlioglu

Objective: This study was conducted to reveal the characteristics of pediatric emergency revisits of children with COVID-19 and the factors associated with clinical worsening and hospitalization at the revisit.

Materials and methods: In pediatric emergency visits of children between July 2020 and March 2021 with COVID-19, the patients who had a revisit within 7 days were included in the study. Demographic and clinical characteristics, test results, and the relationship of these variables with clinical worsening and hospitalization at the revisit were investigated.

Results: In 6779 children with COVID-19, 284 (4.1%) patients included in the study. 51.8% of the patients were male, the median age was 11.1 years, and median time to revisit time was 2.0 days. The rates of clinical worsening and hospitalization were 9.1% and 14.7%, respectively. Children younger than 24 months and those with chronic diseases were more commonly hospitalized at the revisit. Though the frequency of laboratory and radiologic testing at the revisit was significantly increased compared to the first presentation, tests did not play an important role in the decision-making processes. More than 85% of patients were clinically mild at the first presentation and revisit.

Conclusions: Children with a diagnosis of COVID-19 can revisit the emergency without evident clinical worsening. Since revisits cause increase in frequency of laboratory and radiological testing, preventing unnecessary revisits of children with COVID-19 can reduce the workload and cost of health care services. We may consider changing our perspective on revisit patients to make decisions based on clinical findings instead of obtaining for more laboratory tests.

目的:了解新冠肺炎患儿儿科急诊复诊特点及复诊时临床恶化和住院的相关因素。材料与方法:在2020年7月至2021年3月期间COVID-19患儿的儿科急诊就诊中,将7天内再次就诊的患者纳入研究。调查了人口统计学和临床特征、测试结果以及这些变量与再次访问时临床恶化和住院的关系。结果:6779例新冠肺炎患儿中,284例(4.1%)纳入研究。51.8%的患者为男性,中位年龄11.1岁,中位回访时间2.0天。临床恶化率为9.1%,住院率为14.7%。24个月以下的儿童和患有慢性疾病的儿童在复诊时更常住院。虽然与第一次就诊相比,复诊时实验室和放射学检查的频率显著增加,但检查在决策过程中并未发挥重要作用。超过85%的患者在首次就诊和再次就诊时临床症状轻微。结论:诊断为COVID-19的儿童可在无明显临床恶化的情况下再次就诊。由于复诊导致实验室和放射检测频率增加,因此防止对COVID-19儿童进行不必要的复诊可以减少卫生保健服务的工作量和成本。我们可以考虑改变我们对复诊患者的看法,根据临床结果而不是获得更多的实验室检查来做出决定。
{"title":"Pediatric emergency revisits of children with COVID-19.","authors":"Leman Akcan Yildiz,&nbsp;Oznur Karaca Vural,&nbsp;Ali Kansu Tehci,&nbsp;Halise Akca,&nbsp;Funda Kurt,&nbsp;Ayla Akca Caglar,&nbsp;Emine Dibek Misirlioglu","doi":"10.1080/00325481.2022.2157634","DOIUrl":"https://doi.org/10.1080/00325481.2022.2157634","url":null,"abstract":"<p><strong>Objective: </strong>This study was conducted to reveal the characteristics of pediatric emergency revisits of children with COVID-19 and the factors associated with clinical worsening and hospitalization at the revisit.</p><p><strong>Materials and methods: </strong>In pediatric emergency visits of children between July 2020 and March 2021 with COVID-19, the patients who had a revisit within 7 days were included in the study. Demographic and clinical characteristics, test results, and the relationship of these variables with clinical worsening and hospitalization at the revisit were investigated.</p><p><strong>Results: </strong>In 6779 children with COVID-19, 284 (4.1%) patients included in the study. 51.8% of the patients were male, the median age was 11.1 years, and median time to revisit time was 2.0 days. The rates of clinical worsening and hospitalization were 9.1% and 14.7%, respectively. Children younger than 24 months and those with chronic diseases were more commonly hospitalized at the revisit. Though the frequency of laboratory and radiologic testing at the revisit was significantly increased compared to the first presentation, tests did not play an important role in the decision-making processes. More than 85% of patients were clinically mild at the first presentation and revisit.</p><p><strong>Conclusions: </strong>Children with a diagnosis of COVID-19 can revisit the emergency without evident clinical worsening. Since revisits cause increase in frequency of laboratory and radiological testing, preventing unnecessary revisits of children with COVID-19 can reduce the workload and cost of health care services. We may consider changing our perspective on revisit patients to make decisions based on clinical findings instead of obtaining for more laboratory tests.</p>","PeriodicalId":20329,"journal":{"name":"Postgraduate Medicine","volume":"135 4","pages":"379-385"},"PeriodicalIF":4.2,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9311561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prevalence and treatment patterns of familial hypercholesterolemia among Thai patients with premature coronary artery disease. 泰国早发冠心病患者家族性高胆固醇血症的患病率及治疗模式
IF 4.2 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-05-01 DOI: 10.1080/00325481.2023.2182579
Nantiya Nawaka, Chutima Rattanawan, Burabha Pussadhamma, Atthakorn Wutthimanop, Manit Nuinoon, Sureerut Porntadavity, Watcharinthon Theansun, Nutjaree Jeenduang

Objectives: Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder that is characterized by severe hypercholesterolemia. The prevalence of FH in Thailand has not been reported. Therefore, this study aimed to investigate the prevalence of FH and treatment patterns among Thai patients with premature coronary artery disease (pCAD).

Methods: A total of 1,180 pCAD patients at two heart centers from northeastern and southern Thailand between October 2018 and September 2020 were enrolled. FH was diagnosed using the Dutch Lipid Clinic Network (DLCN) criteria. pCAD was diagnosed in men aged < 55 years and women aged < 60 years.

Results: The prevalence of definite/probable FH, possible FH, and unlikely FH in pCAD patients was 1.36% (n = 16), 24.83% (n = 293), and 73.81% (n = 871), respectively. Definite/probable FH in pCAD patients had a significantly higher frequency of STEMI but a lower frequency of hypertension than those with unlikely FH. After discharge, most pCAD patients (95.51%) received statin therapy. Definite/probable FH patients had a higher frequency of high-intensity statin therapy than those with possible FH and unlikely FH. After follow-up for 3-6 months, approximately 54.72% of pCAD patients with DLCN scores ≥ 5 had a reduction in LDL-C > 50% from baseline.

Conclusions: The prevalence of definite/probable FH, particularly possible FH, was high among pCAD patients in this study. The early diagnosis of FH among Thai pCAD patients should be performed for the early treatment and prevention of CAD.

目的:家族性高胆固醇血症(FH)是一种常染色体显性遗传病,以严重的高胆固醇血症为特征。目前尚未报告泰国的FH流行情况。因此,本研究旨在调查FH在泰国过早冠状动脉疾病(pCAD)患者中的患病率和治疗模式。方法:2018年10月至2020年9月,在泰国东北部和南部的两个心脏中心共招募了1180名pad患者。FH的诊断采用荷兰脂质临床网络(DLCN)标准。结果:pCAD患者确诊/可能FH、可能FH、不可能FH的患病率分别为1.36% (n = 16)、24.83% (n = 293)、73.81% (n = 871)。确诊/疑似FH的pCAD患者发生STEMI的频率明显高于未确诊FH的患者,但发生高血压的频率较低。出院后,大多数pCAD患者(95.51%)接受他汀类药物治疗。明确/可能的FH患者比可能的FH和不太可能的FH患者接受高强度他汀类药物治疗的频率更高。随访3-6个月后,约54.72% DLCN评分≥5的pCAD患者LDL-C较基线降低> 50%。结论:本研究中,确诊/可能的FH,特别是可能的FH,在pCAD患者中患病率很高。泰国pCAD患者中FH的早期诊断应用于CAD的早期治疗和预防。
{"title":"The prevalence and treatment patterns of familial hypercholesterolemia among Thai patients with premature coronary artery disease.","authors":"Nantiya Nawaka,&nbsp;Chutima Rattanawan,&nbsp;Burabha Pussadhamma,&nbsp;Atthakorn Wutthimanop,&nbsp;Manit Nuinoon,&nbsp;Sureerut Porntadavity,&nbsp;Watcharinthon Theansun,&nbsp;Nutjaree Jeenduang","doi":"10.1080/00325481.2023.2182579","DOIUrl":"https://doi.org/10.1080/00325481.2023.2182579","url":null,"abstract":"<p><strong>Objectives: </strong>Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder that is characterized by severe hypercholesterolemia. The prevalence of FH in Thailand has not been reported. Therefore, this study aimed to investigate the prevalence of FH and treatment patterns among Thai patients with premature coronary artery disease (pCAD).</p><p><strong>Methods: </strong>A total of 1,180 pCAD patients at two heart centers from northeastern and southern Thailand between October 2018 and September 2020 were enrolled. FH was diagnosed using the Dutch Lipid Clinic Network (DLCN) criteria. pCAD was diagnosed in men aged < 55 years and women aged < 60 years.</p><p><strong>Results: </strong>The prevalence of definite/probable FH, possible FH, and unlikely FH in pCAD patients was 1.36% (n = 16), 24.83% (n = 293), and 73.81% (n = 871), respectively. Definite/probable FH in pCAD patients had a significantly higher frequency of STEMI but a lower frequency of hypertension than those with unlikely FH. After discharge, most pCAD patients (95.51%) received statin therapy. Definite/probable FH patients had a higher frequency of high-intensity statin therapy than those with possible FH and unlikely FH. After follow-up for 3-6 months, approximately 54.72% of pCAD patients with DLCN scores ≥ 5 had a reduction in LDL-C > 50% from baseline.</p><p><strong>Conclusions: </strong>The prevalence of definite/probable FH, particularly possible FH, was high among pCAD patients in this study. The early diagnosis of FH among Thai pCAD patients should be performed for the early treatment and prevention of CAD.</p>","PeriodicalId":20329,"journal":{"name":"Postgraduate Medicine","volume":"135 4","pages":"410-417"},"PeriodicalIF":4.2,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9321393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstracts from the 17th Annual Cardiometabolic Health Congress. 第17届年度心脏代谢健康大会摘要
IF 4.2 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-04-21 DOI: 10.1080/00325481.2023.2187147
{"title":"Abstracts from the 17<sup>th</sup> Annual Cardiometabolic Health Congress.","authors":"","doi":"10.1080/00325481.2023.2187147","DOIUrl":"https://doi.org/10.1080/00325481.2023.2187147","url":null,"abstract":"","PeriodicalId":20329,"journal":{"name":"Postgraduate Medicine","volume":"135 sup2","pages":"1"},"PeriodicalIF":4.2,"publicationDate":"2023-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9678509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microstructural and heavy metal analysis of gallstones prevalent in Jharkhand and its implications in the treatment. 贾坎德邦常见胆结石的显微结构和重金属分析及其治疗意义。
IF 4.2 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-04-01 DOI: 10.1080/00325481.2022.2139973
Bhavna Sharma, Shubha Rani Sharma

Objectives: In the present study the structural and compositional analysis of gallstones was carried out by various characterization techniques. Also, the utility of the study was evaluated on how the findings can enhance the treatment and dissolution therapies of gallstones?

Methods: Gallstones from the Jharkhand region were analyzed both structurally as well as chemically using Field emission scanning electron microscope (FESEM) and Energy-dispersive X-ray spectroscopy, inductively coupled optical emission spectrometry (ICP-OES), Carbon hydrogen and nitrogen analyzer (CHNS), Nuclear magnetic resonance (NMR), Thermal gravimetric analysis (TGA) and Differential Thermal Analysis (DTA) and other instruments. The content of heavy metal was represented statistically as a mean with standard deviation.

Results: FESEM analysis unveiled the crystal and globular structure of cholesterol and pigment gallstones respectively. Through ICP-OES analysis metals such as Fe, Mn, Cu, Pb, Cr, Zn etc. were detected in gallstones. FTIR and XRD analysis confirmed the presence of cholesterol and calcium carbonate and other compounds in mixed stones and calcium bilirubinate and bilirubin in pigment gallstones. NMR analysis revealed the presence of monohydrate cholesterol (Crystalline) in Cholesterol and mixed gallstones. Mixed gallstones were found to be predominant in this region in contrast to pigmented stones that were prevalent earlier.

Conclusion: The present study uncovered the current composition and content of different heavy metals in gallstones of Jharkhand region which can be instrumental in enhancing the dissolution therapies for gallstone treatment. This can serve as a major tool for practitioners for gallstone treatment and change the way they are looked at.

目的:本研究采用各种表征技术对胆结石进行结构和成分分析。此外,该研究的效用被评估为研究结果如何能加强胆结石的治疗和溶解疗法?方法:采用场发射扫描电镜(FESEM)、能量色散x射线能谱、电感耦合发射光谱(ICP-OES)、碳氢氮分析仪(CHNS)、核磁共振(NMR)、热重分析(TGA)和差热分析(DTA)等仪器对贾坎德邦地区胆囊结石进行结构和化学分析。重金属含量在统计上表示为带标准差的平均值。结果:FESEM分析揭示了胆固醇结石和色素结石的晶体和球状结构。通过ICP-OES分析,测定了胆结石中的铁、锰、铜、铅、铬、锌等金属。FTIR和XRD分析证实混合结石中存在胆固醇和碳酸钙等化合物,色素胆结石中存在胆红素钙和胆红素。核磁共振分析显示胆固醇和混合胆结石中存在一水胆固醇(结晶)。混合性胆结石在该区域占主导地位,与早期普遍存在的色素结石形成对比。结论:本研究揭示了贾坎德邦地区胆结石中不同重金属的组成和含量,有助于加强胆结石的溶出治疗。这可以作为一个主要的工具,为从业者胆结石治疗和改变他们的方式看。
{"title":"Microstructural and heavy metal analysis of gallstones prevalent in Jharkhand and its implications in the treatment.","authors":"Bhavna Sharma,&nbsp;Shubha Rani Sharma","doi":"10.1080/00325481.2022.2139973","DOIUrl":"https://doi.org/10.1080/00325481.2022.2139973","url":null,"abstract":"<p><strong>Objectives: </strong>In the present study the structural and compositional analysis of gallstones was carried out by various characterization techniques. Also, the utility of the study was evaluated on how the findings can enhance the treatment and dissolution therapies of gallstones?</p><p><strong>Methods: </strong>Gallstones from the Jharkhand region were analyzed both structurally as well as chemically using Field emission scanning electron microscope (FESEM) and Energy-dispersive X-ray spectroscopy, inductively coupled optical emission spectrometry (ICP-OES), Carbon hydrogen and nitrogen analyzer (CHNS), Nuclear magnetic resonance (NMR), Thermal gravimetric analysis (TGA) and Differential Thermal Analysis (DTA) and other instruments. The content of heavy metal was represented statistically as a mean with standard deviation.</p><p><strong>Results: </strong>FESEM analysis unveiled the crystal and globular structure of cholesterol and pigment gallstones respectively. Through ICP-OES analysis metals such as Fe, Mn, Cu, Pb, Cr, Zn etc. were detected in gallstones. FTIR and XRD analysis confirmed the presence of cholesterol and calcium carbonate and other compounds in mixed stones and calcium bilirubinate and bilirubin in pigment gallstones. NMR analysis revealed the presence of monohydrate cholesterol (Crystalline) in Cholesterol and mixed gallstones. Mixed gallstones were found to be predominant in this region in contrast to pigmented stones that were prevalent earlier.</p><p><strong>Conclusion: </strong>The present study uncovered the current composition and content of different heavy metals in gallstones of Jharkhand region which can be instrumental in enhancing the dissolution therapies for gallstone treatment. This can serve as a major tool for practitioners for gallstone treatment and change the way they are looked at.</p>","PeriodicalId":20329,"journal":{"name":"Postgraduate Medicine","volume":"135 3","pages":"296-311"},"PeriodicalIF":4.2,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9161190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sports and exercise medicine clinic in public hospital settings: a real-life concept and experiences of the treatment of the first 1151 patients. 公立医院的体育和运动医学诊所:第一批1151名患者的现实生活概念和治疗经验。
IF 4.2 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-04-01 DOI: 10.1080/00325481.2022.2135894
Lauri Alanko, Jari A Laukkanen, Mirva Rottensteiner, Salla Rasmus, Tero Kuha, Maarit Valtonen, Urho M Kujala

Objective: Physical exercise has been shown to have a variety of health-promoting effects, including improvements in cardiorespiratory and muscular fitness, symptoms and risk factors such as LDL and HDL cholesterol, triglyceride and glycosylated hemoglobin concentrations. Regular physical exercise may slow down or even reverse the progression of various non-communicable diseases (NCDs). Despite the overwhelming evidence, physical exercise is not comprehensively used as a treatment component either in primary care or in hospital settings.

Methods: The outpatient Sports and Exercise Medicine Clinic (SEMC) is the first specialized clinic in Finland to use physical exercise as a part of the public health care system. Patients needing specialist attention due to NCDs, usually combined with sedentary lifestyles, are referred to the clinic.

Results: The prerequisites for patient referral are the known efficacy of physical exercise intervention in the treatment of disease and the need for sports and exercise medicine expertise. The focus of the clinic is to implement physical activity into daily life with other health-promoting habits such as diet, rest and the reduction of substance use. In addition, SEMC promotes the inclusion of physical exercise in several local treatment guidelines in the hospital district. The advisory treatment protocol of SEMC consists of a baseline evaluation, face-to-face visits with a physician and/or physiotherapist at 3, 6 and 9-12 months, and contacts via phone between hospital visits. Laboratory tests, body composition, walking tests, and measurements of muscle strength and balance are performed at baseline, and body composition and physical tests are repeated after 6 and 9-12 months.

Conclusions: At the core of the treatment is individualization, using motivational interviewing, considering the patients' personal interests and resources, and encouraging the patient to be an active member of our multi-professional team. We reported the first results in the SEMC with future development plans for the clinic.

目的:体育锻炼已被证明具有多种促进健康的作用,包括改善心肺和肌肉健康,改善症状和危险因素,如LDL和HDL胆固醇,甘油三酯和糖化血红蛋白浓度。有规律的体育锻炼可以减缓甚至逆转各种非传染性疾病的进展。尽管有压倒性的证据,体育锻炼并没有被全面用作初级保健或医院环境中的治疗组成部分。方法:门诊运动和运动医学诊所(SEMC)是芬兰第一家将体育锻炼作为公共卫生保健系统一部分的专业诊所。因非传染性疾病而需要专科治疗的患者,通常与久坐不动的生活方式相结合,被转介到诊所。结果:患者转诊的先决条件是已知的体育锻炼干预治疗疾病的疗效和需要的运动和运动医学专业知识。诊所的重点是将体育活动融入日常生活,同时养成其他促进健康的习惯,如饮食、休息和减少物质使用。此外,SEMC还推动将体育锻炼纳入医院区的一些当地治疗指南。SEMC的咨询治疗方案包括基线评估,在第3,6和9-12个月时与医生和/或物理治疗师面对面访问,以及在医院访问之间通过电话联系。在基线时进行实验室测试、身体成分、步行测试、肌肉力量和平衡测量,并在6个月和9-12个月后重复身体成分和身体测试。结论:治疗的核心是个性化,采用动机性访谈,考虑患者的个人兴趣和资源,并鼓励患者成为我们多专业团队的积极成员。我们在SEMC上报告了第一个结果,并为临床提供了未来的发展计划。
{"title":"Sports and exercise medicine clinic in public hospital settings: a real-life concept and experiences of the treatment of the first 1151 patients.","authors":"Lauri Alanko,&nbsp;Jari A Laukkanen,&nbsp;Mirva Rottensteiner,&nbsp;Salla Rasmus,&nbsp;Tero Kuha,&nbsp;Maarit Valtonen,&nbsp;Urho M Kujala","doi":"10.1080/00325481.2022.2135894","DOIUrl":"https://doi.org/10.1080/00325481.2022.2135894","url":null,"abstract":"<p><strong>Objective: </strong>Physical exercise has been shown to have a variety of health-promoting effects, including improvements in cardiorespiratory and muscular fitness, symptoms and risk factors such as LDL and HDL cholesterol, triglyceride and glycosylated hemoglobin concentrations. Regular physical exercise may slow down or even reverse the progression of various non-communicable diseases (NCDs). Despite the overwhelming evidence, physical exercise is not comprehensively used as a treatment component either in primary care or in hospital settings.</p><p><strong>Methods: </strong>The outpatient Sports and Exercise Medicine Clinic (SEMC) is the first specialized clinic in Finland to use physical exercise as a part of the public health care system. Patients needing specialist attention due to NCDs, usually combined with sedentary lifestyles, are referred to the clinic.</p><p><strong>Results: </strong>The prerequisites for patient referral are the known efficacy of physical exercise intervention in the treatment of disease and the need for sports and exercise medicine expertise. The focus of the clinic is to implement physical activity into daily life with other health-promoting habits such as diet, rest and the reduction of substance use. In addition, SEMC promotes the inclusion of physical exercise in several local treatment guidelines in the hospital district. The advisory treatment protocol of SEMC consists of a baseline evaluation, face-to-face visits with a physician and/or physiotherapist at 3, 6 and 9-12 months, and contacts via phone between hospital visits. Laboratory tests, body composition, walking tests, and measurements of muscle strength and balance are performed at baseline, and body composition and physical tests are repeated after 6 and 9-12 months.</p><p><strong>Conclusions: </strong>At the core of the treatment is individualization, using motivational interviewing, considering the patients' personal interests and resources, and encouraging the patient to be an active member of our multi-professional team. We reported the first results in the SEMC with future development plans for the clinic.</p>","PeriodicalId":20329,"journal":{"name":"Postgraduate Medicine","volume":"135 3","pages":"283-289"},"PeriodicalIF":4.2,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9162972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short night-time sleep duration is associated with thyroid nodules: A community-based survey from Guangzhou, China. 夜间睡眠时间短与甲状腺结节有关:来自中国广州的一项社区调查。
IF 4.2 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-04-01 DOI: 10.1080/00325481.2022.2139485
Yuerong Yan, Xiaoyi Wang, Hongshi Wu, Caixia Chen, Xiaohui Li, Rongxue Yang, Feng Li, Li Yan, Muchao Mu, Mingtong Xu

Background: Sleep plays a critical role in maintaining human health. This study aimed to explore the association between sleep status and thyroid nodules.

Methods: A total of 2414 individuals aged 18 or older with euthyroidism were enrolled in this community-based survey. Sleep status was self-reported. Thyroid ultrasonography was performed to measure nodules. Multiple logistic analyses were applied to adjust for confounding factors.

Results: The percentages of thyroid nodules among individuals who slept <5 hours, 5-8 hours, and >8 hours per night were 57.79% (115/199), 44.19% (833/1885) and 42.73% (141/330), respectively (p = 0.001). Individuals who slept <5 hours per night had a significantly higher percentage of thyroid nodules than those who slept 5-8 hours per night (57.79% vs. 44.19%, p = 0.001) or >8 hours per night (57.79% vs. 42.73%, P < 0.001). However, no similar result was shown between individuals who slept >8 hours and 5-8 hours per night (42.73% vs. 44.19%, p = 0.621). Multiple logistic analysis showed that a sleep duration of <5 hours per night was significantly associated with thyroid nodules (odds ratio (OR) 1.643, 95% confidence interval (CI) 1.084-2.490, p = 0.019) when compared to a sleep duration of >8 hours per night. However, a sleep duration of <5 hours per night was not associated with thyroid nodules compared to a sleep duration of 5-8 hours (OR 1.294, 95% CI 0.918-1.824, p = 0.141). Similarly, no significant differences were seen among sleep duration per day, time of falling asleep, habit of daytime napping or thyroid nodules in multiple logistic analyses (all p > 0.05).

Conclusions: Short nighttime sleep duration was associated with thyroid nodules in our community-based population. Screening for thyroid nodules among these individuals is recommended.

背景:睡眠对维持人体健康起着至关重要的作用。本研究旨在探讨睡眠状态与甲状腺结节的关系。方法:共有2414名18岁及以上的甲亢患者参加了这项以社区为基础的调查。睡眠状态是自我报告的。甲状腺超声检查结节。采用多重逻辑分析对混杂因素进行校正。结果:8小时睡眠人群甲状腺结节患病率分别为57.79%(115/199)、44.19%(833/1885)和42.73%(141/330),差异有统计学意义(p = 0.001)。每晚睡8小时的个体(57.79% vs. 42.73%, P为8小时和5-8小时)(42.73% vs. 44.19%, P = 0.621)。多重逻辑分析表明,每晚睡眠时间为8小时。然而,睡眠时间为0.05)。结论:在我们的社区人群中,夜间睡眠时间短与甲状腺结节有关。建议对这些人进行甲状腺结节筛查。
{"title":"Short night-time sleep duration is associated with thyroid nodules: A community-based survey from Guangzhou, China.","authors":"Yuerong Yan,&nbsp;Xiaoyi Wang,&nbsp;Hongshi Wu,&nbsp;Caixia Chen,&nbsp;Xiaohui Li,&nbsp;Rongxue Yang,&nbsp;Feng Li,&nbsp;Li Yan,&nbsp;Muchao Mu,&nbsp;Mingtong Xu","doi":"10.1080/00325481.2022.2139485","DOIUrl":"https://doi.org/10.1080/00325481.2022.2139485","url":null,"abstract":"<p><strong>Background: </strong>Sleep plays a critical role in maintaining human health. This study aimed to explore the association between sleep status and thyroid nodules.</p><p><strong>Methods: </strong>A total of 2414 individuals aged 18 or older with euthyroidism were enrolled in this community-based survey. Sleep status was self-reported. Thyroid ultrasonography was performed to measure nodules. Multiple logistic analyses were applied to adjust for confounding factors.</p><p><strong>Results: </strong>The percentages of thyroid nodules among individuals who slept <5 hours, 5-8 hours, and >8 hours per night were 57.79% (115/199), 44.19% (833/1885) and 42.73% (141/330), respectively (p = 0.001). Individuals who slept <5 hours per night had a significantly higher percentage of thyroid nodules than those who slept 5-8 hours per night (57.79% vs. 44.19%, p = 0.001) or >8 hours per night (57.79% vs. 42.73%, P < 0.001). However, no similar result was shown between individuals who slept >8 hours and 5-8 hours per night (42.73% vs. 44.19%, p = 0.621). Multiple logistic analysis showed that a sleep duration of <5 hours per night was significantly associated with thyroid nodules (odds ratio (OR) 1.643, 95% confidence interval (CI) 1.084-2.490, p = 0.019) when compared to a sleep duration of >8 hours per night. However, a sleep duration of <5 hours per night was not associated with thyroid nodules compared to a sleep duration of 5-8 hours (OR 1.294, 95% CI 0.918-1.824, p = 0.141). Similarly, no significant differences were seen among sleep duration per day, time of falling asleep, habit of daytime napping or thyroid nodules in multiple logistic analyses (all p > 0.05).</p><p><strong>Conclusions: </strong>Short nighttime sleep duration was associated with thyroid nodules in our community-based population. Screening for thyroid nodules among these individuals is recommended.</p>","PeriodicalId":20329,"journal":{"name":"Postgraduate Medicine","volume":"135 3","pages":"290-295"},"PeriodicalIF":4.2,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9161185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Undergraduate health sciences students' response regarding COVID-19 pandemic in Saudi Arabia: an observational study. 沙特阿拉伯健康科学本科学生对COVID-19大流行的反应:一项观察性研究
IF 4.2 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-04-01 DOI: 10.1080/00325481.2021.2017184
Ayman Geddawy, Mansour Alajmi, Abdulaziz M Alaskar, Salman T Alwadani, Abdulaziz F Alanezi, Abdullah Abdurahman Alhomaidhi, Sameer Al-Ghamdi

Background: The coronavirus disease 2019 (COVID-19) pandemic represents a major health problem, and its influences may persist with emerging viral variants. The current work was to evaluate the knowledge, attitude, and learning satisfaction of health sciences students (HSS) regarding the COVID-19 pandemic.

Methods: A questionnaire-based cross-sectional study was conducted from 20 February 2021 to 20 March 2021. Participants were undergraduate HSS at Prince Sattam bin Abdulaziz University in Al Kharj, Saudi Arabia. The questionnaire has been generated and distributed via online form. The questionnaire used was based on previous studies and included demographic information and knowledge, attitudes, perception, and learning satisfaction related to the COVID-19 pandemic.

Results: Out of the 400 questionnaires distributed to eligible students, the current study included a total of 330 HSS (82.5% response rate) from colleges of medicine (25.5%), dentistry (11.8%), pharmacy (33.6%), and Applied Medical Sciences (29.1%) of participants. The mean scores of knowledge, attitude, and learning satisfaction attained by students were 5.63 ± 0.65 out of 6, 4.22 ± 1.01 out of 5, and 11.28 ± 2.9 out of 19, respectively. Results show an association between the knowledge score of students and their age-group and specialty-college. Students with chronic diseases reported lower attitude scores and rate of COVID-19 vaccine-willingness. Younger HSS had a higher learning satisfaction score than the older participants.

Conclusion: Overall, participants show high knowledge level and positive attitude toward COVID-19 but fair learning satisfaction during the pandemic. Further studies are needed to improve the learning satisfaction and attitude of HSS in the future.

背景:2019冠状病毒病(COVID-19)大流行是一个重大的健康问题,其影响可能会随着新出现的病毒变体而持续存在。本研究旨在评估健康科学专业学生(HSS)对COVID-19大流行的知识、态度和学习满意度。方法:从2021年2月20日至2021年3月20日进行了一项基于问卷的横断面研究。参与者是沙特阿拉伯阿勒哈里王子萨塔姆·本·阿卜杜勒阿齐兹大学的本科HSS。该问卷已通过在线表格生成和分发。所使用的问卷基于以往的研究,包括与COVID-19大流行相关的人口统计信息和知识、态度、感知和学习满意度。结果:本研究共向符合条件的学生发放400份问卷,共纳入330名HSS(回复率82.5%),分别来自医学院校(25.5%)、牙科院校(11.8%)、药学院校(33.6%)和应用医学院校(29.1%)。学生的知识、态度和学习满意度平均得分分别为5.63±0.65分(6分)、4.22±1.01分(5分)和11.28±2.9分(19分)。结果表明,学生的知识得分与其年龄、专业院校存在一定的相关性。患有慢性疾病的学生态度得分和COVID-19疫苗意愿率较低。年轻HSS的学习满意度得分高于年长HSS。结论:总体而言,参与者在疫情期间对新冠肺炎的知识水平和态度较高,但学习满意度一般。未来需要进一步的研究来提高高专学生的学习满意度和态度。
{"title":"Undergraduate health sciences students' response regarding COVID-19 pandemic in Saudi Arabia: an observational study.","authors":"Ayman Geddawy,&nbsp;Mansour Alajmi,&nbsp;Abdulaziz M Alaskar,&nbsp;Salman T Alwadani,&nbsp;Abdulaziz F Alanezi,&nbsp;Abdullah Abdurahman Alhomaidhi,&nbsp;Sameer Al-Ghamdi","doi":"10.1080/00325481.2021.2017184","DOIUrl":"https://doi.org/10.1080/00325481.2021.2017184","url":null,"abstract":"<p><strong>Background: </strong>The coronavirus disease 2019 (COVID-19) pandemic represents a major health problem, and its influences may persist with emerging viral variants. The current work was to evaluate the knowledge, attitude, and learning satisfaction of health sciences students (HSS) regarding the COVID-19 pandemic.</p><p><strong>Methods: </strong>A questionnaire-based cross-sectional study was conducted from 20 February 2021 to 20 March 2021. Participants were undergraduate HSS at Prince Sattam bin Abdulaziz University in Al Kharj, Saudi Arabia. The questionnaire has been generated and distributed via online form. The questionnaire used was based on previous studies and included demographic information and knowledge, attitudes, perception, and learning satisfaction related to the COVID-19 pandemic.</p><p><strong>Results: </strong>Out of the 400 questionnaires distributed to eligible students, the current study included a total of 330 HSS (82.5% response rate) from colleges of medicine (25.5%), dentistry (11.8%), pharmacy (33.6%), and Applied Medical Sciences (29.1%) of participants. The mean scores of knowledge, attitude, and learning satisfaction attained by students were 5.63 ± 0.65 out of 6, 4.22 ± 1.01 out of 5, and 11.28 ± 2.9 out of 19, respectively. Results show an association between the knowledge score of students and their age-group and specialty-college. Students with chronic diseases reported lower attitude scores and rate of COVID-19 vaccine-willingness. Younger HSS had a higher learning satisfaction score than the older participants.</p><p><strong>Conclusion: </strong>Overall, participants show high knowledge level and positive attitude toward COVID-19 but fair learning satisfaction during the pandemic. Further studies are needed to improve the learning satisfaction and attitude of HSS in the future.</p>","PeriodicalId":20329,"journal":{"name":"Postgraduate Medicine","volume":"135 3","pages":"234-243"},"PeriodicalIF":4.2,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9162621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Biomarkers for the diagnosis and treatment of rheumatoid arthritis - a systematic review. 类风湿性关节炎诊断和治疗的生物标志物系统综述。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-04-01 Epub Date: 2022-03-16 DOI: 10.1080/00325481.2022.2052626
D Abdelhafiz, T Baker, D A Glascow, Ah Abdelhafiz

Background: Rheumatoid arthritis (RA) is an autoimmune disease, symmetrically affecting the small joints. Biomarkers are tools that can be used in the diagnosis and monitoring of RA.

Aim: To systematically explore the role of the biomarkers: C-reactive protein (CRP), rheumatoid factor (RF), anti-cyclic citrullinated protein (Anti-CCP), 14-3-3η protein, and the multi-biomarker disease activity (MBDA) score for the diagnosis and treatment of RA.

Methods: A systematic review of the English literature using four different databases was carried out.

Results: CRP >7.1 mg/L predicted poor conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) outcome in RA. Anti-CCP, CRP ≥0.3 mg/dL, and RF predicted bone erosion and cartilage destruction. Combination of high 14-3-3η protein with RF and CRP improved the prediction of rapid erosion progression (REP). Anti-CCP was not associated with disease activity but was associated with increased radiographic damage (r = 0.46, p = 0.048). RF was not associated with joint damage but correlated with ultrasound-detected bone erosion. The 14-3-3η protein significantly correlated with inflammation, bone rremodeling, and osteoporosis in RA patients (p < 0.05). In addition, the 14-3-3η protein positively correlated with RA duration (p = 0.003), disease aactivity, and positive RF (p = 0.025) and it distinguished early from established RA. Early MBDA scores correlated with later response in disease activity after 6 and 12 weeks of treatment (p < 0.05). The MBDA score was able to differentiate between small differences in disease activity, predicted remission over 1-year pperiod, and was a strong predictor of radiographic progression of RA.

Conclusion: The investigated biomarkers are helpful tools in clinical practice for diagnosis, monitoring of treatment, and predicting prognosis in RA patients. However, further research is still required to investigate novel biomarkers for the pre-treatment selection of potentially responsive patients before starting therapy for a precision medicine in this area.

背景:类风湿性关节炎(RA)是一种对称性影响小关节的自身免疫性疾病。生物标志物是可用于RA诊断和监测的工具。目的:系统探讨c反应蛋白(CRP)、类风湿因子(RF)、抗环瓜氨酸化蛋白(Anti-CCP)、14-3-3η蛋白及多生物标志物疾病活度(MBDA)评分在RA诊断和治疗中的作用。方法:使用四个不同的数据库对英文文献进行系统回顾。结果:CRP >7.1 mg/L预测常规合成疾病缓解抗风湿药物(csDMARDs)预后较差。Anti-CCP、CRP≥0.3 mg/dL和RF预测骨侵蚀和软骨破坏。高14-3-3η蛋白与RF和CRP的结合提高了对快速侵蚀进展(REP)的预测。抗ccp与疾病活动无关,但与放射学损伤增加相关(r = 0.46, p = 0.048)。RF与关节损伤无关,但与超声检测的骨侵蚀相关。14-3-3η蛋白与RA患者的炎症、骨重塑和骨质疏松有显著相关性(p)结论:所研究的生物标志物在RA患者的诊断、治疗监测和预测预后方面具有重要的临床应用价值。然而,在该领域的精准医学开始治疗之前,仍需要进一步研究新的生物标志物,以在治疗前选择潜在的反应性患者。
{"title":"Biomarkers for the diagnosis and treatment of rheumatoid arthritis - a systematic review.","authors":"D Abdelhafiz, T Baker, D A Glascow, Ah Abdelhafiz","doi":"10.1080/00325481.2022.2052626","DOIUrl":"10.1080/00325481.2022.2052626","url":null,"abstract":"<p><strong>Background: </strong>Rheumatoid arthritis (RA) is an autoimmune disease, symmetrically affecting the small joints. Biomarkers are tools that can be used in the diagnosis and monitoring of RA.</p><p><strong>Aim: </strong>To systematically explore the role of the biomarkers: C-reactive protein (CRP), rheumatoid factor (RF), anti-cyclic citrullinated protein (Anti-CCP), 14-3-3η protein, and the multi-biomarker disease activity (MBDA) score for the diagnosis and treatment of RA.</p><p><strong>Methods: </strong>A systematic review of the English literature using four different databases was carried out.</p><p><strong>Results: </strong>CRP >7.1 mg/L predicted poor conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) outcome in RA. Anti-CCP, CRP ≥0.3 mg/dL, and RF predicted bone erosion and cartilage destruction. Combination of high 14-3-3η protein with RF and CRP improved the prediction of rapid erosion progression (REP). Anti-CCP was not associated with disease activity but was associated with increased radiographic damage (r = 0.46, p = 0.048). RF was not associated with joint damage but correlated with ultrasound-detected bone erosion. The 14-3-3η protein significantly correlated with inflammation, bone rremodeling, and osteoporosis in RA patients (p < 0.05). In addition, the 14-3-3η protein positively correlated with RA duration (p = 0.003), disease aactivity, and positive RF (p = 0.025) and it distinguished early from established RA. Early MBDA scores correlated with later response in disease activity after 6 and 12 weeks of treatment (p < 0.05). The MBDA score was able to differentiate between small differences in disease activity, predicted remission over 1-year pperiod, and was a strong predictor of radiographic progression of RA.</p><p><strong>Conclusion: </strong>The investigated biomarkers are helpful tools in clinical practice for diagnosis, monitoring of treatment, and predicting prognosis in RA patients. However, further research is still required to investigate novel biomarkers for the pre-treatment selection of potentially responsive patients before starting therapy for a precision medicine in this area.</p>","PeriodicalId":20329,"journal":{"name":"Postgraduate Medicine","volume":"135 3","pages":"214-223"},"PeriodicalIF":2.6,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9159671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin D and COVID-19: where are we now? 维生素 D 和 COVID-19:进展如何?
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-04-01 Epub Date: 2021-12-27 DOI: 10.1080/00325481.2021.2017647
Victoria Contreras-Bolívar, Beatriz García-Fontana, Cristina García-Fontana, Manuel Muñoz-Torres

The pandemic caused by the SARS-CoV-2 virus has triggered great interest in the search for the pathophysiological mechanisms of COVID-19 and its associated hyperinflammatory state. The presence of prognostic factors such as diabetes, cardiovascular disease, hypertension, obesity, and age influence the expression of the disease's clinical severity. Other elements, such as 25-hydroxyvitamin D (25(OH)D3) concentrations, are currently being studied. Various studies, mostly observational, have sought to demonstrate whether there is truly a relationship between 25(OH)D3 levels and the acquisition and/or severity of the disease. The objective of this study was to carry out a review of the current data that associate vitamin D status with the acquisition, evolution, and/or severity of infection by the SARS-CoV-2 virus and to assess whether prevention through vitamin D supplementation can prevent infection and/or improve the evolution once acquired. Vitamin D system has an immunomodulatory function and plays a significant role in various bacterial and viral infections. The immune function of vitamin D is explained in part by the presence of its receptor (VDR) and its activating enzyme 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1) in immune cells. The vitamin D, VDR, and Retinoid X Receptor complex allows the transcription of genes with antimicrobial activities, such as cathelicidins and defensins. COVID-19 characteristically presents a marked hyperimmune state, with the release of proinflammatory cytokines such as IL-6, TNF-α, and IL-1β. Thus, there are biological factors linking vitamin D to the cytokine storm, which can herald some of the most severe consequences of COVID-19, such as acute respiratory distress syndrome. Hypovitaminosis D is widespread worldwide, so the prevention of COVID-19 through vitamin D supplementation is being considered as a possible therapeutic strategy easy to implement. However, more-quality studies and well-designed randomized clinical trials are needed to address this relevant question.

由 SARS-CoV-2 病毒引起的大流行引发了人们对 COVID-19 及其相关高炎症状态的病理生理机制的极大兴趣。糖尿病、心血管疾病、高血压、肥胖和年龄等预后因素的存在会影响疾病临床严重程度的表现。目前正在研究其他因素,如 25- 羟维生素 D(25(OH)D3)浓度。各种研究(大多为观察性研究)都试图证明 25(OH)D3 水平与疾病的发生和/或严重程度之间是否存在真正的关系。本研究的目的是对维生素 D 状态与 SARS-CoV-2 病毒感染的获得、演变和/或严重程度相关的现有数据进行回顾,并评估通过补充维生素 D 是否可以预防感染和/或改善感染后的演变。维生素 D 系统具有免疫调节功能,在各种细菌和病毒感染中发挥着重要作用。维生素 D 免疫功能的部分原因是其受体(VDR)及其活化酶 25-羟基维生素 D-1α-羟化酶(CYP27B1)存在于免疫细胞中。维生素 D、VDR 和视黄醇 X 受体复合物可以转录具有抗菌活性的基因,如柔毛素和防御素。COVID-19 的特征性表现是明显的免疫功能亢进状态,并释放促炎细胞因子,如 IL-6、TNF-α 和 IL-1β。因此,有一些生物因素将维生素 D 与细胞因子风暴联系起来,而细胞因子风暴可能预示着 COVID-19 最严重的后果,如急性呼吸窘迫综合征。维生素 D 缺乏症在全球普遍存在,因此通过补充维生素 D 来预防 COVID-19 被认为是一种易于实施的治疗策略。然而,要解决这一相关问题,还需要进行更多高质量的研究和精心设计的随机临床试验。
{"title":"Vitamin D and COVID-19: where are we now?","authors":"Victoria Contreras-Bolívar, Beatriz García-Fontana, Cristina García-Fontana, Manuel Muñoz-Torres","doi":"10.1080/00325481.2021.2017647","DOIUrl":"10.1080/00325481.2021.2017647","url":null,"abstract":"<p><p>The pandemic caused by the SARS-CoV-2 virus has triggered great interest in the search for the pathophysiological mechanisms of COVID-19 and its associated hyperinflammatory state. The presence of prognostic factors such as diabetes, cardiovascular disease, hypertension, obesity, and age influence the expression of the disease's clinical severity. Other elements, such as 25-hydroxyvitamin D (25(OH)D3) concentrations, are currently being studied. Various studies, mostly observational, have sought to demonstrate whether there is truly a relationship between 25(OH)D3 levels and the acquisition and/or severity of the disease. The objective of this study was to carry out a review of the current data that associate vitamin D status with the acquisition, evolution, and/or severity of infection by the SARS-CoV-2 virus and to assess whether prevention through vitamin D supplementation can prevent infection and/or improve the evolution once acquired. Vitamin D system has an immunomodulatory function and plays a significant role in various bacterial and viral infections. The immune function of vitamin D is explained in part by the presence of its receptor (VDR) and its activating enzyme 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1) in immune cells. The vitamin D, VDR, and Retinoid X Receptor complex allows the transcription of genes with antimicrobial activities, such as cathelicidins and defensins. COVID-19 characteristically presents a marked hyperimmune state, with the release of proinflammatory cytokines such as IL-6, TNF-α, and IL-1β. Thus, there are biological factors linking vitamin D to the cytokine storm, which can herald some of the most severe consequences of COVID-19, such as acute respiratory distress syndrome. Hypovitaminosis D is widespread worldwide, so the prevention of COVID-19 through vitamin D supplementation is being considered as a possible therapeutic strategy easy to implement. However, more-quality studies and well-designed randomized clinical trials are needed to address this relevant question.</p>","PeriodicalId":20329,"journal":{"name":"Postgraduate Medicine","volume":"135 3","pages":"195-207"},"PeriodicalIF":2.6,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787834/pdf/IPGM_0_2017647.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9216144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The debate over the optimal blood pressure treatment target of less than 130/80 mmHg. 关于低于130/80 mmHg的最佳血压治疗目标的争论。
IF 4.2 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-04-01 DOI: 10.1080/00325481.2022.2052516
Steven G Chrysant

Objectives: The objective of this study was to analyze the controversy regarding the optimal blood pressure (BP) target of <130/80 mmHg as proposed by the 2017 American College of Cardiology/American Heart Association (ACC/AHA) across all age groups. Hypertension is a major risk factor for cardiovascular disease (CVD), stroke, and chronic kidney disease (CKD), and its optimal control is associated with lessening or preventing these complications. A recent study has argued that this BP level is universally accepted as an optimal and safe BP level. However, this argument is not accepted by other investigators, arguing that higher BP levels are as effective and safe.

Methods: In order to investigate the current status of this level of BP control, a Medline search of the English literature was conducted between 2017 and February 2022, and 25 pertinent papers were selected.

Results: The analysis of data from these studies indicates that these BP are effective in lowering the BP and preventing cardiovascular disease, heart failure, and chronic kidney disease, and they are indeed universally accepted.

Conclusion: Based on the current evidence, the current proposed by the 2017 ACC/AHA treatment guidelines are effective in lowering the BP and decreasing its cardiovascular complications and should followed, till perhaps, new data come out to the contrary.

目的:本研究的目的是分析关于方法的最佳血压(BP)目标的争议:为了调查该血压控制水平的现状,我们在Medline上检索了2017年至2022年2月的英文文献,从中选择了25篇相关论文。结果:通过对这些研究数据的分析表明,这些血压对降低血压、预防心血管疾病、心力衰竭和慢性肾脏疾病都是有效的,确实是普遍接受的。结论:根据目前的证据,2017年ACC/AHA治疗指南提出的当前治疗方案在降低血压和减少心血管并发症方面是有效的,应该继续遵循,直到可能出现相反的新数据。
{"title":"The debate over the optimal blood pressure treatment target of less than 130/80 mmHg.","authors":"Steven G Chrysant","doi":"10.1080/00325481.2022.2052516","DOIUrl":"https://doi.org/10.1080/00325481.2022.2052516","url":null,"abstract":"<p><strong>Objectives: </strong>The objective of this study was to analyze the controversy regarding the optimal blood pressure (BP) target of <130/80 mmHg as proposed by the 2017 American College of Cardiology/American Heart Association (ACC/AHA) across all age groups. Hypertension is a major risk factor for cardiovascular disease (CVD), stroke, and chronic kidney disease (CKD), and its optimal control is associated with lessening or preventing these complications. A recent study has argued that this BP level is universally accepted as an optimal and safe BP level. However, this argument is not accepted by other investigators, arguing that higher BP levels are as effective and safe.</p><p><strong>Methods: </strong>In order to investigate the current status of this level of BP control, a Medline search of the English literature was conducted between 2017 and February 2022, and 25 pertinent papers were selected.</p><p><strong>Results: </strong>The analysis of data from these studies indicates that these BP are effective in lowering the BP and preventing cardiovascular disease, heart failure, and chronic kidney disease, and they are indeed universally accepted.</p><p><strong>Conclusion: </strong>Based on the current evidence, the current proposed by the 2017 ACC/AHA treatment guidelines are effective in lowering the BP and decreasing its cardiovascular complications and should followed, till perhaps, new data come out to the contrary.</p>","PeriodicalId":20329,"journal":{"name":"Postgraduate Medicine","volume":"135 3","pages":"208-213"},"PeriodicalIF":4.2,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9530565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Postgraduate Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1